Aspartame Not Linked to Non-Hodgkin's Lymphoma

Investigators from the American Cancer Society's Epidemiology Research Program in Atlanta have concluded that the artificial sweetener aspartame, often dubiously linked to cancer, is not linked to the development of lymphoma in older adults.

Marjorie L McCullough and colleagues, believing that the existing data was contradictory, examined possible associations between the consumption of sweetened carbonated beverages and aspartame intake with overall risk of non-Hodgkin lymphoma (and risk by major histologic subtype).

These data are derived from the long-range Cancer Prevention Study--II Nutrition Cohort. To learn more about this large study, click on the link above to be taken to the American Cancer Society's information page.

Looking at data provided by over 100,000 men and women in 1999, the research team determined that the rate of lymphomas (there was no variable risk among subtypes) was no higher among those who consumed aspartame or consumed artificially and sugar-sweetened carbonated beverages daily compared with people that reported no aspartame intake or did not consume such beverages as frequently.

They concluded that their findings "do not support associations of daily consumption of artificially or sugar-sweetened carbonated beverages, or aspartame, with NHL risk."

Source: The Journal of Nutrition

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap